Evaluation of SOX2 as a potential marker for ameloblastic carcinoma.

MLA

Lei, Yu, et al. “Evaluation of SOX2 as a Potential Marker for Ameloblastic Carcinoma.” Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, vol. 117, no. 5, May 2014, p. 608–616.e1. EBSCOhost, https://doi.org/10.1016/j.oooo.2014.01.017.

APA

Lei, Y., Jaradat, J. M., Owosho, A., Adebiyi, K. E., Lybrand, K. S., Neville, B. W., Mã, ller, S., & Bilodeau, E. A. (2014). Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, 117(5), 608–616.e1. https://doi.org/10.1016/j.oooo.2014.01.017

Chicago

Lei, Yu, Jumana M. Jaradat, Adepitan Owosho, Kehinde E. Adebiyi, Kelley S. Lybrand, Brad W. Neville, ller, Susan Mã, and Elizabeth A. Bilodeau. 2014. “Evaluation of SOX2 as a Potential Marker for Ameloblastic Carcinoma.” Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology 117 (5): 608–616.e1. doi:10.1016/j.oooo.2014.01.017.